Leiomyoma clinical trials at UCSF

1 research study open to eligible people

Leiomyoma are benign growths in the uterus. UCSF is testing whether letrozole can shrink these growths compared to a placebo. This trial is important for assessing new treatment methods for uterine myomas.

Showing trials for

  • Prescription of Letrozole for Uterine Myoma

    open to eligible females ages 21-53

    The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.

    San Francisco, California and other locations

Our lead scientists for Leiomyoma research studies include .

Last updated: